Johns Hopkins Drug Discovery - John Hopkins University
The Johns Hopkins Drug Discovery Program continues to work with the researchers across Johns Hopkins to research and develop tomorrow’s therapeutics for a wide range of human disorders.
Johns Hopkins, Drug Discovery, Transforming academic translational research
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-2,bridge-core-3.0.5,qi-blocks-1.0.6,qodef-gutenberg--no-touch,qodef-qi--no-touch,qi-addons-for-elementor-1.5.5,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-29.1,qode-theme-bridge,disabled_footer_bottom,wpb-js-composer js-comp-ver-6.9.0,vc_responsive,elementor-default,elementor-kit-3247,x-shortcodes-v3_0_5
Johns Hopkins University Drug Discovery

Transforming academic
translational research

Expertise in drug
discovery research

Developing for the future

What’s New?

JHDD researchers lead a breakthrough study published in Science Advances showing anti-cancer effects of novel compound DRP-104 that is the basis of a current clinical trial

Click here to read more

JHDD-developed glutamine antagonist receives Fast Track designation from FDA for small-cell lung cancer

JHDD-cofounded PSMA Therapeutics acquired by Bayer AG

JHDD coauthors a report showing glutamine antagonism overcomes tumor immune invasion [Science]

JHDD received a UG3 grant through the HEAL initiative to develop new a new treatment for neuropathic pain

Click here to read more

Building innovative partnerships

Johns Hopkins University Drug Discovery - JHU Drug Discovery

Our high throughput screening collaboration with Eisai represents an innovative way to create synergy between complimentary organizations to develop new therapeutics.

Interested in Working With Us?

We welcome opportunities to discuss how we can work together in a drug discovery collaboration.